Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)

This study was designed to evaluate the safety, tolerability, efficacy and pharmacokinetics of JK-1201I combined with adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme after surgery and concomitant radio-chemotherapy.

Participants needed: 25
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: JenKem Technology Co., Ltd.Updated: Sep 19, 2024Locations: 1
Eligibility criteria

Male or female aged ≥18 years and ≤75 years. [+19]

Read more
Status: Not yet recruiting

JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

This study was designed to evaluate the safety, efficacy and pharmacokinetics of JK-1201I in triple negative breast cancer patients with brain metastases.

Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: JenKem Technology Co., Ltd.Updated: Sep 19, 2024
Eligibility criteria

Sign and date the informed consent form prior to the start of any study-specific... [+26]

Read more
Status: Not yet recruiting

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

This study was designed to compare the efficacy and safety of JK-1201I with Topotecan in patients with relapsed extensive stage small cell lung cancer (ES SCLC).

Participants needed: 394
Trial details
Phase: Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: JenKem Technology Co., Ltd.Updated: Sep 3, 2024
Eligibility criteria

Sign and date the informed consent form prior to the start of any study-specific... [+5]

Hypersensitivity to any ingredient of JK-1201I and Topotecan. [+10]

Read more